MEI Pharma (MEIP) Announces CFO Retirement

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that Brian Drazba, chief financial officer of MEI Pharma, has informed the company that he is retiring. Mr. Drazba, an industry veteran who has overseen financial operations since joining in April 2017, will continue to serve in his current role and provide transitional support through the end of 2021.

"On behalf of the entire MEI team, I would like to thank Brian for his contributions and leadership over the last four years," said Daniel P. Gold, Ph.D., president and chief executive officer of MEI Pharma. "Brian has played a prominent role in MEI's growth over the years and in building and strengthening the company's financial infrastructure. I personally wish Brian all the best in his next chapter."

Ahead of Mr. Drazba's retirement, the company has initiated a search for a new chief financial officer.

You May Also Be Interested In

• 22nd Century Group (XXII) Announces Resignation of Sullivan and Mish from Board
• Jaguar Health (JAGX) Appoints Miller Collis as SVP of Growth Strategy
• Rocket Lab USA (RKLB) Announces Board Change